Roivant Sciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Roivant Sciences Ltd. (ROIV) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar 2025Dec 2024Mar 2024Mar 2023Mar 2022
Current Assets
Cash and Cash Equivalents2.722.726.541.682.06
Short-Term Investments2.172.170.000.000.00
Cash & Short-Term Investments4.894.896.541.682.06
Accounts Receivable0.000.000.040.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.110.110.200.120.09
Total Current Assets5.005.006.731.802.15
Non-Current Assets
Property, Plant & Equipment (Net)0.100.100.070.090.09
Long-Term Investments0.300.300.300.330.29
Intangible Assets0.000.000.140.000.00
Other Non-Current Assets0.030.030.040.050.03
Total Non-Current Assets0.440.440.490.590.44
Total Assets5.445.447.222.392.59
Current Liabilities
Accounts Payable0.020.020.230.200.16
Short-Term Debt0.000.010.040.000.00
Current Portion of Long-Term Debt0.000.000.040.000.00
Accrued Liabilities0.060.070.170.080.08
Deferred Revenue0.000.000.010.010.01
Other Current Liabilities0.000.110.040.080.01
Total Current Liabilities0.150.150.290.340.18
Non-Current Liabilities
Long-Term Debt0.090.090.480.430.27
Other Non-Current Liabilities0.010.010.000.020.02
Total Non-Current Liabilities0.100.100.480.450.34
Total Liabilities0.250.250.770.780.52
Stockholders' Equity
Retained Earnings0.120.120.57-3.78-2.76
Accumulated Other Comprehensive Income0.010.000.000.00-0.10
Additional Paid-in Capital4.565.405.404.934.42
Minority Interest0.500.500.480.450.40
Shares Outstanding0.700.810.760.690.00
Total Stockholders' Equity4.694.696.451.612.06
Total Liabilities & Equity5.445.447.222.392.59